Journal article
Validation of a patient decision aid for choosing between dabigatran and warfarin for atrial fibrillation.
Abstract
BACKGROUND: Decision aids have been helpful to support patients in decision-making including anticoagulation. With the introduction of new oral anticoagulants (NOACs), it will be important to assist patients and physicians in shared decision-making about NOACs and warfarin.
OBJECTIVES: To validate a patient decision aid (DA) for warfarin versus dabigatran, the first NOAC approved for atrial fibrillation (AF).
Authors
Hong C; Kim S; Curnew G; Schulman S; Pullenayegum E; Holbrook A
Journal
Journal of Population Therapeutics and Clinical Pharmacology, Vol. 20, No. 3, pp. e229–e237
Publication Date
2013
ISSN
1710-6222